A Dual-Marker DNA Methylation Assay Enables High-Sensitivity Detection of Malignant Effusions Across Cancer Types
Simple Summary Distinguishing malignant from benign pleural and peritoneal effusions is essential for cancer diagnosis and treatment, but routine cytology often fails to detect malignant cells. We evaluated a DNA methylation test based on two cancer-related genes, SHOX2 and RASSF1A, in 696 patients with pleural or peri...